Supreme Court Gives Some Relief, But Leaves Open Questions For Dx Patents

Diagnostics and biotech firms praised a June 28 Supreme Court opinion for allowing judges some flexibility in ruling on the patent-eligibility of "process" claims, but patent attorneys warn that many issues remain unsettled